Toni Cathomen

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Albert-Ludwigs-Universitaet Freiburg, University of London, Albert-Ludwigs-Universitat Freiburg. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toni Cathomen. Retrieved from https://idiyas.com/inventor/toni-cathomen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 12(Granted Patents)

Company Filing History:

6 out of 47

Albert-Ludwigs-Universitaet Freiburg

Albert-Ludwigs-Universitat Freiburg

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

patents

where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492389 - MODIFIED CAS9 SYSTEM HAVING A DOMINANT NEGATIVE EFFECTOR ON NON-HOMOLOGOUS END-JOINING FUSED THERETO AND ITS USE FOR IMPROVED GENE EDITING (2025-12-09),

2. 12428492 - Chimeric antigen receptors that bind to prostate specific membrane antigen (2025-09-30),

3. 11957794 - Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells (2024-04-16),

4. 11767512 - Sequence specific reagents targeting CCR5 in primary hematopoietic cells (2023-09-26),

5. 11319580 - Method for characterization of modifications caused by the use of designer nucleases (2022-05-03),

6. 11253482 - Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells (2022-02-22),

7. 11072782 - Construct for epigenetic modification and its use in the silencing of genes (2021-07-27),

Title: Inventor Toni Cathomen: Revolutionizing Biotechnology in Freiburg

Introduction: Toni Cathomen, a pioneering inventor based in Freiburg, Germany, is renowned for his groundbreaking work in the field of biotechnology. With a passion for innovation and a drive to improve lives through his inventions, Cathomen has made significant contributions to the scientific community.

Latest Patents: Cathomen's latest patents focus on gene editing technologies that have the potential to revolutionize the treatment of genetic disorders. His innovative approaches have garnered attention worldwide for their potential to transform the way we address genetic diseases.

Career Highlights: Throughout his illustrious career, Cathomen has held key positions in leading research institutions and biotechnology companies. His expertise in gene editing and molecular biology has led to the development of cutting-edge technologies that are at the forefront of the biotech industry.

Collaborations: Cathomen has collaborated with top researchers, scientists, and biotech companies to further advance the field of biotechnology. His collaborative efforts have resulted in groundbreaking discoveries and innovative solutions that have the potential to shape the future of healthcare.

Conclusion: Inventor Toni Cathomen's dedication to pushing the boundaries of biotechnology and gene editing has established him as a visionary in the field. His innovative spirit and commitment to scientific excellence continue to inspire the next generation of inventors and researchers in Freiburg and beyond.

Profile summary based on public USPTO records.